Valuation Arch Biopartners Inc.

Equities

Market Closed - OTC Markets Other stock markets 19:04:51 13/03/2026 GMT			5-day change	1st Jan Change
0.4975 ^USD	-4.16%		-13.70%	-43.68%

03-03	Arch Biopartners Inc. Reports Earnings Results for the First Quarter Ended December 31, 2025	CI
02-09	Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease	CI

Data adjusted to current consolidation scope

Fiscal Period: September	2020	2021	2022	2023	2024	2025
Capitalization ¹	83.27	106.5	186.6	68.59	113.5	85.12
Change	-	27.95%	75.09%	-63.23%	65.53%	-25.03%
Enterprise Value (EV) ¹	86.01	111.3	190.5	72.78	116.3	87.96
Change	-	29.36%	71.18%	-61.79%	59.82%	-24.38%
P/E ratio	-23.6x	-90.2x	-132x	-20.6x	-28.4x	-54.4x
PBR	-28.7x	-27.4x	-41.7x	-12.4x	-26.1x	-21.9x
PEG	-	1.2x	-7x	-0x	-1.8x	0.9x
Capitalization / Revenue	1,227x	27.4x	193x	34.6x	53.5x	308x
EV / Revenue	1,267x	28.6x	197x	36.7x	54.8x	319x
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-19.6x	-136x	-191x	-25.1x	-33.7x	-77.5x
EV / FCF	-613x	-43.8x	314x	106x	-89.8x	-73.8x
FCF Yield	-0.16%	-2.28%	0.32%	0.94%	-1.11%	-1.35%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0772	-0.0191	-0.0226	-0.0533	-0.0619	-0.0237
Distribution rate	-	-	-	-	-	-
Net sales ¹	0.0679	3.887	0.9647	1.984	2.122	0.2759
EBITDA	-	-	-	-	-	-
EBIT ¹	-4.379	-0.8194	-0.9971	-2.896	-3.456	-1.134
Net income ¹	-4.629	-1.17	-1.408	-3.327	-3.92	-1.553
Net Debt ¹	2.737	4.716	3.906	4.185	2.767	2.838
Reference price ²	1.8253	1.7196	2.9930	1.0957	1.7562	1.2876
Nbr of stocks (in thousands)	60,782	61,962	62,330	62,599	64,651	66,106
Announcement Date	28/01/21	28/01/22	30/01/23	29/01/24	29/01/25	29/01/26

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ARCH BIOPARTNERS INC.	-	-	-	-	34.75M
ELI LILLY AND COMPANY	28.72x	10.82x	21.74x	0.68%	873B
JOHNSON & JOHNSON	25.68x	5.98x	16.28x	2.19%	583B
ABBVIE INC.	24.62x	6.7x	13.46x	3.08%	398B
ROCHE HOLDING AG	17.19x	4.19x	10.36x	3.16%	324B
ASTRAZENECA PLC	24.12x	5.03x	13.93x	1.73%	297B
NOVARTIS AG	20.99x	5.66x	13.99x	2.86%	294B
MERCK & CO., INC.	27.09x	4.75x	14.85x	2.91%	287B
AMGEN INC.	24.74x	6.28x	11.18x	2.73%	198B
GILEAD SCIENCES, INC.	20.13x	6.12x	11.08x	2.24%	180B
Average	23.70x	6.17x	14.09x	2.4%	343.54B
Weighted average by Cap.	24.76x	6.94x	15.69x	2.11%